Hey guys,
Hope you’re all doing well!
I applied for my CCT a few days ago, which means I’ll finally be a qualified GP (or consultant in family medicine).
It’s been a long time coming, and I can’t help but reminisce of all the things I did to get here.
From doing work experience in nursing homes and dialysis units to nervously interviewing for medical school; from sitting OSCE exams with real patients to publishing academic research and presenting it internationally; working night shifts, across numerous specialities, whilst doing countless exams, and even working through a pandemic as an F1 doctor.
I got into medical school in 2013.
It was a long road just to get there, too. But here we are, 13 years on. Alhamdulillah (praise be to God).
For many, they’d sit comfortably at this stage for decades to come, and well deserved.
But I’m not sure I can do that exactly, and I’m excited to share what’s to come.
These next few years will be very interesting!
🔗 The Weekly Link-Up
I saw this video the other day, and couldn’t help but share it.
The MHRA's independent commission, led by NHS doctors, has set out how AI should be regulated in healthcare: staged authorisations for new models, continuous real world monitoring once they are live, and safety information the public can actually look up.
Novo has signed with Anthropic to use Claude Science across research and development, saying it wants to become the world's most AI-driven healthcare company.
The college says NHS England's neighbourhood contract proposals are not acceptable in their current form. ‘Neighbourhood Health Services’ will replace PCNs to form single neighbourhood providers or multi-neighbourhood providers, offloading care from hospitals and shifting them to communities instead.
Berkeley researchers gave semaglutide to older female mice and got approximately 100 extra days of life, along with better muscle and cognitive function, compared with untreated mice. They also compared with mice who were calorie-restricted, to see if those beneficial effects were simply down to a reduction in calories, or the GLP-1 itself.
Researchers ran a full multi-omic workup on Maria Branyas, who died at 117, and found Branyas had ‘genetic characteristics associated to neuroprotection and cardioprotection, genuinely low inflammatory levels, a microbiome dominated by beneficial bifidobacteria, and a biological age younger than her chronological age, as determined by epigenetic markers.’
Qualcomm Ventures backed a round valuing Ultrahuman at $365m, with the plan being rings that do rather more than track you: on device compute, AI interaction, even games. They are aiming at a $200m annual run rate by January 2027.
Abbott's Libre DUO is the first FDA authorised sensor reading both glucose and ketones, with minute to minute glucose and an alert when ketones start rising.
See you next week!
Dr Fai J
📹 This Week on the Channel
Everything Wrong with AI Scribes
I have used AI scribes for many months now, so this is a list of what I dislike about them, and where I think things could go wrong.
British opinions on Private Healthcare
Some genuinely interesting objective data on what the British public thinks about private healthcare, and what they understand about what it costs.
How much exercise do you get in a week?
A challenge to the WHO’s recommendation of exercise needed per week.
🤓 About Me
I'm Faisal, a Doctor working in the NHS who's passionate about longevity, wellness and healthtech.
Website: www.faisaljamshaid.com - home to my newsletter, blog, creative videos and more.
SocialPrescriber.co.uk - I built a FREE directory for patients across England to help them find local community support without a GP appointment. Check it out here.
Recommended Links: Fav Productivity Tool | Get 20% off My Automated Newsletter Provider | Fav Medical Scribe | 50% off My Automated Video Editor
Disclaimer: I use sponsored ads/affiliate links in this newsletter (always honest recommendations). They give me a small kickback with no extra cost to you.